Your new post is loading...
One of the great frustrations for researchers in the war on cancer is that the body’s own defense system does not do a better job fighting the disease. Tumors, it turns out, have a molecular shield that repels attacks from the immune system.
Now, a new study says, an experimental drug is showing promise in disabling that shield...
